-
Development of a Method for Assessing the Effectiveness of Alpha-synuclein Immunotherapy
… participating in our clinical trial will be purified from serum and characterized for their binding and … by PMCA will also be performed on CSF samples collected from participants receiving either UB-312 treatment or …
-
Preventing Fractures in Parkinson’s Disease by Identifying Barriers to Care and Social Determinants of Health
… and the poor—and in people with PD who do not get care from a neurologist or seek medication or physical therapy. … We also will explore whether obtaining care and treatment from a neurologist helps prevent fractures in people with …
-
Evaluating a Microbial Biomarker in Blood Samples for Parkinson’s Disease
… can be detected in bacterial DNA sequences obtained from blood samples, and that distinct patterns of microbial … Study Design: We will mine whole genome sequencing data from blood samples of people with PD and healthy …
-
Subtyping Parkinson’s Disease Using Genetic and Intestinal Inflammation Biomarkers
… disease progression. Lastly, we will compare genomic data from the brains of people with PD with those from individuals with inflammatory bowel disease and …
-
Pathophysiology of Neural Circuits Underlying Pain in Prodromal to Advanced Parkinson’s Disease
… Many people with Parkinson’s disease (PD) suffer from pain that is not managed well by existing therapies. We … of PD pain. Finally, we will use advanced techniques from multiple scientific disciplines to show how cells in …
-
Episode 4: Elucidating the Pathobiology of LRRK2 in Parkinson's Disease with Dr. Dario Alessi
December 5, 2023
… disease (PD) risk in 2004. Since then, researchers from around the world have advanced our understanding of the … to The Michael J. Fox Foundation Parkinson’s Podcast. Hear from scientists, doctors and people with Parkinson's on …